CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Cochlear Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02309099
NCT02309099N/ACompleted

Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach

University of North Carolina, Chapel Hill·interventional·Posted Dec 5, 2014·Updated Jan 7, 2019

In Brief

A clinical study evaluating Cochlear Implant for Unilateral Acoustic Neuroma and Meniere's Disease. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The goal of this project is to determine whether subjects who have undergone labyrinthectomy or a translabyrinthine surgical approach as the treatment for vestibular schwannoma or Meniere's disease benefit from cochlear implantation on speech perception and localization tasks. If the auditory nerve is able to transmit this signal effectively, then these two populations may be able to utilize the combination of electric (in the affected ear) and acoustic (in the non-affected ear) information for improved speech perception in noise and localization as reportedly experienced in other unilateral sensorineural hearing loss populations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMed-El Corporation

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 5, 2014
Enrollment StartNov 1, 2014
Primary CompletionNov 8, 2017
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 11.6 years ago

Interventions

Cochlear Implantdevice

Cochlear implantation used a treatment for single-sided deafness resultant of labyrinthectomy or a translabyrinthine surgical approach